Age group at diagnosis, year
| | |
0.031
| | |
0.033
|
< 40
|
1
|
–
|
–
|
1
|
–
|
–
|
40–49
|
0.572
|
0.352–0.927
|
0.024
|
0.587
|
0.361–0.956
|
0.032
|
50–59
|
0.774
|
0.486–1.233
|
0.281
|
0.923
|
0.571–1.493
|
0.946
|
≥60
|
0.520
|
0.305–0.886
|
0.016
|
0.684
|
0.390–1.200
|
0.237
|
Education level
| | |
0.200
| | | |
High school or below
|
1
|
–
| | | | |
College or above
|
1.272
|
0.881–1.836
| | | | |
Marital status
| | | | | | |
Married or cohabitation
|
1
|
–
| | | | |
Unmarried or divorced or widowed
|
1.105
|
0.814–1.501
|
0.522
| | | |
Family income, HKD/month
|
< 30,000
|
1
|
–
| | | | |
≥30,000
|
1.184
|
0.855–1.638
|
0.310
| | | |
Employment status
| | | | | | |
Working
|
1
|
–
| | | | |
Not working
|
1.228
|
0.928–1.625
|
0.150
| | | |
Number of comorbidities
| | |
0.006
| | |
0.009
|
0
|
1
|
–
| |
1
|
–
| |
1
|
0.878
|
0.633–1.217
|
0.434
|
0.859
|
0.610–1.210
|
0.385
|
≥2
|
0.418
|
0.245–0.713
|
0.001
|
0.417
|
0.238–0.732
|
0.002
|
Menopausal status from T0 to
| | |
0.445
| | | |
T3 assessment
| | | | | | |
Pre-menopausal
|
1
|
–
| | | | |
Peri-menopausal
|
1.146
|
0.760–1.727
|
0.515
| | | |
Post-menopausal
|
0.941
|
0.629–1.409
|
0.768
| | | |
Parity
| | |
0.259
| | | |
0
|
1
|
–
| | | | |
≥1
|
0.832
|
0.605–1.145
| | | | |
AJCC stage
| | |
0.203
| | | |
0-I
|
1
|
–
| | | | |
II
|
0.840
|
0.620–1.136
|
0.258
| | | |
III
|
0.691
|
0.452–1.057
|
0.089
| | | |
ER status, %
|
Positive
|
1
| | |
1
| | |
Negative
|
0.663
|
0.471–0.933
|
0.019
|
0.624
|
0.440–0.886
|
0.008
|
PR status, %
|
Positive
|
1
| | | | | |
Negative
|
0.895
|
0.674–1.189
|
0.444
| | | |
HER 2 status, %
|
Positive
|
1
| | | | | |
Negative
|
1.124
|
0.814–1.554
|
0.478
| | | |
Type of surgery
|
Mastectomy
|
1
|
–
| | | | |
Conservation
|
1.236
|
0.931–1.640
|
0.143
| | | |
Chemotherapy, %
|
No
|
1
|
–
| | | | |
Yes
|
0.780
|
0.571–1.065
|
0.118
| | | |
Radiotherapy, %
|
No
|
1
| | | | | |
Yes
|
1.081
|
0.794–1.472
|
0.621
| | | |
Endocrine therapy, %
|
No
|
1
|
–
| | | | |
Yes
|
1.229
|
0.882–1.712
|
0.223
| | | |
Average sports participation
| | |
0.655
| | | |
from T1 to T3 assessment
| | | | | | |
Never
|
1
|
–
| | | | |
Rarely/occasionally
|
0.843
|
0.543–1.311
|
0.449
| | | |
Frequently
|
0.942
|
0.595–1.491
|
0.799
| | | |
Average dietary energy intake from T1 to T3 assessment
|
≤median
|
1
|
–
| | | | |
>median
|
1.010
|
0.764–1.336
|
0.943
| | | |
Average dietary carbohydrate intake from T1 to T3
|
assessment, g/1000 kcal/day
| | | | | | |
≤median
|
1
|
–
| | | | |
>median
|
1.052
|
0.796–1.391
|
0.722
| | | |
Average dietary fat intake from T1 to T3 assessment, g/1000
|
kcal/day
| | | | | | |
≤median
|
1
|
–
| | | | |
>median
|
1.096
|
0.829–1.449
|
0.522
| | | |
Average vegetables and fruits intake from T1 to T3 assessment, g/day
|
< 400
|
1
|
–
| | | | |
≥400
|
0.792
|
0.550–1.140
|
0.210
| | | |
Average coffee intake from T1 to T3 assessment, ml/week
|
< 200
|
1
|
–
| | | | |
≥200
|
0.914
|
0.662–1.261
|
0.584
| | | |
Average sugar-sweetened beverage intake from T1 to T3
|
assessment, ml/week
| | | | | | |
< 200
|
1
|
–
| | | | |
≥200
|
0.802
|
0.489–1.316
|
0.383
| | | |